Is There an Age Limit for a Trial of Vaginal Delivery in Nulliparous Women?

advanced maternal age cesarean section elderly primipara first vaginal delivery labor and delivery pregnancy complications

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
23 May 2023
Historique:
received: 16 04 2023
revised: 08 05 2023
accepted: 17 05 2023
medline: 10 6 2023
pubmed: 10 6 2023
entrez: 10 6 2023
Statut: epublish

Résumé

The number of nulliparous women over the age of 35 is consistently increasing, and the optimal delivery strategy is a subject of ongoing discussion. This study compares perinatal outcomes in nulliparous women aged ≥35 years undergoing a trial of labor (TOL) versus a planned cesarean delivery (CD). A retrospective cohort study including all nulliparous women ≥ 35 years who delivered a single term fetus at a single center between 2007-2019. We compared obstetric and perinatal outcomes according to mode of delivery-TOL versus a planned CD, in three different age groups: (1) 35-37 years, (2) 38-40 years, and (3) >40 years. Out of 103,920 deliveries during the study period, 3034 women met the inclusion criteria. Of them, 1626 (53.59%) were 35-37 years old (group 1), 848 (27.95%) were 38-40 (group 2), and 560 (18.46%) were >40 years (group 3). TOL rates decreased as age increased: 87.7% in group 1, 79.3% in group 2, and 50.1% in group 3, A TOL at advanced maternal age appears to be safe, with considerable success rates. As maternal age advances, there is a small additive risk of intrapartum CD.

Sections du résumé

BACKGROUND BACKGROUND
The number of nulliparous women over the age of 35 is consistently increasing, and the optimal delivery strategy is a subject of ongoing discussion. This study compares perinatal outcomes in nulliparous women aged ≥35 years undergoing a trial of labor (TOL) versus a planned cesarean delivery (CD).
METHODS METHODS
A retrospective cohort study including all nulliparous women ≥ 35 years who delivered a single term fetus at a single center between 2007-2019. We compared obstetric and perinatal outcomes according to mode of delivery-TOL versus a planned CD, in three different age groups: (1) 35-37 years, (2) 38-40 years, and (3) >40 years.
RESULTS RESULTS
Out of 103,920 deliveries during the study period, 3034 women met the inclusion criteria. Of them, 1626 (53.59%) were 35-37 years old (group 1), 848 (27.95%) were 38-40 (group 2), and 560 (18.46%) were >40 years (group 3). TOL rates decreased as age increased: 87.7% in group 1, 79.3% in group 2, and 50.1% in group 3,
CONCLUSIONS CONCLUSIONS
A TOL at advanced maternal age appears to be safe, with considerable success rates. As maternal age advances, there is a small additive risk of intrapartum CD.

Identifiants

pubmed: 37297815
pii: jcm12113620
doi: 10.3390/jcm12113620
pmc: PMC10253403
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Obstet Gynaecol Res. 2022 Sep;48(9):2377-2384
pubmed: 35751564
Arch Gynecol Obstet. 2011 Jul;284(1):31-7
pubmed: 20632182
Clin Perinatol. 2008 Jun;35(2):373-93, vii
pubmed: 18456075
Acta Med Port. 2019 Mar 29;32(3):219-226
pubmed: 30946794
Eur J Obstet Gynecol Reprod Biol X. 2023 Feb 08;17:100180
pubmed: 36846599
Am J Obstet Gynecol. 2016 Mar;214(3):362.e1-7
pubmed: 26454124
BMC Pregnancy Childbirth. 2018 Aug 22;18(1):343
pubmed: 30134873
Isr Med Assoc J. 2005 May;7(5):311-4
pubmed: 15909464
Obstet Gynecol. 1995 Jan;85(1):65-70
pubmed: 7800328
Matern Child Health J. 2016 Nov;20(11):2318-2327
pubmed: 27473092
Sci Rep. 2020 Feb 4;10(1):1809
pubmed: 32020027
Am J Obstet Gynecol. 2012 Feb;206(2):139.e1-5
pubmed: 22051815
Acta Obstet Gynecol Scand. 2022 Sep;101(9):1026-1032
pubmed: 35841162
Natl Vital Stat Rep. 2021 Feb;70(17):1-50
pubmed: 35157571
Birth. 2010 Sep;37(3):219-26
pubmed: 20887538
J Obstet Gynaecol. 2014 Aug;34(6):479-81
pubmed: 24786586
Obstet Gynecol. 2022 Aug 1;140(2):348-366
pubmed: 35852294
Obstet Gynecol. 2005 May;105(5 Pt 1):983-90
pubmed: 15863534
Am J Obstet Gynecol. 2010 Dec;203(6):558.e1-7
pubmed: 20965486
J Reprod Med. 2011 Jan-Feb;56(1-2):25-30
pubmed: 21366123
BMC Pregnancy Childbirth. 2021 Feb 12;21(1):126
pubmed: 33579220
N Engl J Med. 2018 Aug 09;379(6):513-523
pubmed: 30089070
Obstet Gynecol. 2018 Mar;131(3):457-463
pubmed: 29420406
Acta Obstet Gynecol Scand. 2020 Feb;99(2):283-289
pubmed: 31583694
Acta Obstet Gynecol Scand. 2012 Jul;91(7):816-23
pubmed: 22435923
PLoS One. 2017 Oct 17;12(10):e0186287
pubmed: 29040334
PLoS One. 2019 Nov 26;14(11):e0225074
pubmed: 31770385
J Obstet Gynaecol Can. 2009 Dec;31(12):1124-30
pubmed: 20085677
N Engl J Med. 2016 Mar 3;374(9):813-22
pubmed: 26962902

Auteurs

Gil Zeevi (G)

Helen Schneider Hospital for Women, Rabin Medical Center, Petach-Tikva 4941492, Israel.

Rita Zlatkin (R)

Helen Schneider Hospital for Women, Rabin Medical Center, Petach-Tikva 4941492, Israel.

Alyssa Hochberg (A)

Helen Schneider Hospital for Women, Rabin Medical Center, Petach-Tikva 4941492, Israel.

Shir Danieli-Gruber (S)

The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997505, Israel.

Ohad Houri (O)

Helen Schneider Hospital for Women, Rabin Medical Center, Petach-Tikva 4941492, Israel.

Eran Hadar (E)

Helen Schneider Hospital for Women, Rabin Medical Center, Petach-Tikva 4941492, Israel.

Asnat Walfisch (A)

Helen Schneider Hospital for Women, Rabin Medical Center, Petach-Tikva 4941492, Israel.

Avital Wertheimer (A)

Helen Schneider Hospital for Women, Rabin Medical Center, Petach-Tikva 4941492, Israel.

Classifications MeSH